BiomX Inc. 8-K Summary
Business Context and Reporting Period
BiomX Inc. (PHGE), a Delaware corporation headquartered in Ness Ziona, Israel, filed this Current Report on Form 8-K on February 27, 2025. The report details the closing of a capital raising event that occurred on February 25, 2025, and was finalized on February 27, 2025.
Key Financial Metrics
- Gross Proceeds: Approximately $12 million raised from the Offering.
- Offering Structure: Included a registered direct offering, a concurrent private placement, and the exercise of certain existing warrants.
- Shares Outstanding: 24,996,053 shares of common stock issued and outstanding as of March 5, 2025.
- Net Proceeds: The filing states gross proceeds before deducting placement agent fees and other offering expenses; net proceeds are not specified.
- Other Metrics: The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity positions.
Material Changes
The primary material change is the increase in share count and cash inflow resulting from the Offering. The total number of shares outstanding increased to 24,996,053 following the transaction. No comparative financial data for prior periods is included in this specific filing.
Outlook, Risks, and Management Commentary
The filing confirms the successful closing of the Offering. It does not contain forward-looking guidance, management commentary on future operations, specific risk factors, or details on unusual items beyond the capital raise itself.
Investor Verification Checklist
- Verify the exact net proceeds after deducting placement agent fees and offering expenses.
- Confirm the specific terms and pricing of the registered direct offering and private placement components.
- Review the dilution impact of the 24,996,053 outstanding shares on existing shareholders.
- Check subsequent filings for the intended use of the $12 million in gross proceeds.